Tag: #Global Trends

Bristol Myers Squibb (BMS) has announced that the European Commission (EC) has approved Sotyktu (deucravacitinib) for the treatment of active... Read more

Gilead Sciences has revised its 2026 sales forecast for Yeztugo (lenacapivir), its twice-yearly HIV pre-exposure prophylaxis (PrEP) medication. Following a... Read more

Kenvue Inc., the maker of Tylenol, beat Wall Street estimates for first-quarter revenue and profit on Thursday. The positive performance... Read more

Halozyme Therapeutics Inc. and GSK have entered into a global collaboration and license agreement. Under the terms, GSK has licensed... Read more

Altasciences, an integrated drug development solution company, and Certara, a global leader in model-informed drug development, have launched a strategic... Read more

Blackstone Life Sciences is making a $250 million investment in Anagram Therapeutics, a clinical-stage biopharmaceutical company. The funding is designated... Read more

Pharmaceutical giant Eli Lilly has unveiled plans to invest an additional $4.5 billion into its Lebanon campus in Indiana. This... Read more

After a period of volatility, Danish pharmaceutical giant Novo Nordisk reported positive signals in Q1 2026. The most significant highlight... Read more

French pharmaceutical giant Sanofi has reportedly requested to remove its application for the expanded use of the diabetes drug Tzield... Read more